NEI is the preeminent provider of continuing education and practice-based tools for healthcare professionals who treat patients with mental health disorders.
Thousands of clinicians consider NEI their top mental health resource for point of care answers and continuing medical education (CME). Here's why:
NEI Prescribe, our prescribing app, features over 150 psychiatric medications and has a dedicated Child and Adolescent section with in-depth coverage of the most commonly prescribed psychotropic drugs in pediatric patients. Continuously updated and with an interactive filter to search for medications based on key drug interactions and side effects, NEI Prescribe is your tool for point of care prescribing. Our two annual conferences—NEI Congress in the fall and NEI Synapse in the spring—fuse learning, quality, and entertainment into an educational experience that will empower you to provide the best possible care for your patients. We offer hundreds of online CME activities, including animations, case studies, self-assessments, and encore presentations from NEI's live events. The Master Psychopharmacology Program is an online assessment-based certificate program designed to help clinicians develop proficiency in the practice of psychopharmacology. Create a free NEI account at http://nei.global to take advantage of these resources. NEI Membership is required to access the full spectrum of resources, including the Master Psychopharmacology Program. Learn more at http://nei.global/mbroverview. Neuroscience Education Institute, An HMP Global Company
12/26/2025
Best of 2025! Here’s a look back at some of the most relevant research and developments that took place in psychosis and schizophrenia, including:
– Relapse Criteria in Schizophrenia
– Clozapine Shows Greater Benefit in Schizoaffective Disorder
– Efficacy and Safety of Brexpiprazole in Adolescents with Schizophrenia
– Population Study Reveals Most Effective Antipsychotic Strategies for First-Episode Schizophrenia
– Cannabidiol Fails to Protect Against Cannabis-Induced Symptoms in Schizophrenia
Read more:
Here’s a look back at some of the most relevant research and developments that took place in schizophrenia
12/25/2025
As 2025 comes to an end, we want to thank you for your dedication to mental health care and for being part of the NEI community. It brings us great joy to support your continuing education! We send you good wishes and hopes for a happy, healthy New Year!
Cheers!
The NEI Team
12/22/2025
We invites all scientific professionals in the mental healthcare field to submit an abstract for presentation at the annual NEI Spring Congress Scientific Poster Session. Deadline is February 6th. Submit now ➡️
NEI invites all scientific professionals in the mental healthcare field to submit an abstract for presentation at the annual NEI Spring Congress Scientific Poster Session.
12/18/2025
What a year in psychopharmacology! Drs. Andrew Cutler and Roger McIntyre reflect on the most impactful breakthroughs and what they mean for practice. Tune in and stay ahead of the curve.
Join Drs. Andy Cutler and Roger McIntyre as they discuss the most significant advancements in psychopharmacology over the past year. Their conversation highlights groundbreaking developments and innovations in the field of psychiatry.
12/12/2025
Sleep difficulties are widespread in young adults, with some individuals turning to substances in hopes of initiating their sleep. A recent national analysis examined cannabis and alcohol use for sleep in over 1,400 U.S. young adults aged 19 to 30. Read more:
Sleep difficulties are widespread in young adults, with some individuals turning to substances in hopes of initiating their sleep. A recent national analysis examined cannabis and alcohol use for sleep in over 1,400 U.S. young adults aged 19 to 30.
12/11/2025
Wrap up the year with savings and start the new one with exclusive NEI Member benefits! Become an NEI Member before December 31 and get $50 off the regular price. Join todayt:
Invest in your professional growth before the year ends—offer expires soon
12/03/2025
Join Dr. Andrew Cutler, Dr. Stephen M. Stahl, MD, PhD, and Dr. Roger McIntyre in this CME/CE episode as they explore how clinicians can better recognize and manage complex depression, with a focus on major depressive episodes featuring mixed or anxious features. Listen now on the NEI Podcast
In this CME episode, Dr. Andy Cutler talks with Drs. Stephen Stahl and Roger McIntyre about recognizing and managing complex depression, particularly major depressive episodes with mixed or anxious features.
12/02/2025
Relapse prevention is critical in long-term schizophrenia management. However, despite its importance, definitions of relapse vary widely across clinical trials, which makes it difficult to compare studies or interpret meta-analyses. To address this issue, a recent publication aimed to establish standardized, operational definitions of relapse to improve consistency in trial design, analysis, and interpretation. Read more
Relapse prevention is critical in long-term schizophrenia management. However, despite its importance, definitions of relapse vary widely across clinical trials, which makes it difficult to compare studies or interpret meta-analyses.
11/26/2025
Holiday travel ahead? Bring NEI Podcast along for the ride.
Our latest CME episode delivers practical insights on managing complex bipolar I disorder care, from mixed states to long-term maintenance. Tune in now: https://nei.global/e269
Managing bipolar I disorder is rarely straightforward, and today’s clinicians are challenged to balance polypharmacy, evolving symptom presentations, patient preferences, and long-term functional goals. This CME episode brings clarity to those complexities with practical, evidence-based strategies you can apply immediately in clinical practice.
In this CME episode, Dr. Andy Cutler and Dr. Christoph Correll discuss the complexities of managing bipolar disorder, with a focus on recognizing and treating mixed states.
11/26/2025
The NEI Faculty are back, tackling the internet’s most searched questions on today’s most talked-about mental health topics. Here, Dr. Andrew Cutler and Dr. Roger McIntyre break down what clinicians and patients are asking about GLP-1 receptor agonists– from how they work, to their metabolic and psychiatric implications, to what the latest evidence means for practice.
Curious about the link between GLP-1s and mood? NEI has you covered!
Enjoy the latest perk of NEI Membership! Say hello to the NEI Clinical Toolkit. A powerful new member benefit designed to help you make confident, evidence-based clinical decisions. Start exploring now ➡️
A powerful member benefit that helps you make confident, informed clinical decisions.
11/20/2025
Your questions, answered! 💬 In Episode 268 of the NEI Podcast, our experts tackle your unanswered questions from 2025 NEI Fall Congress in Colorado Springs.
Tune in now:
This episode includes extended Q&A sessions that address your unanswered questions from presentations delivered at the 2025 Fall Congress in Colorado Springs, Colorado
Be the first to know and let us send you an email when Neuroscience Education Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to Neuroscience Education Institute:
Thousands of clinicians consider NEI their top mental health resource for point of care answers and continuing medical education (CME). Here's why:
NEI Prescribe, our prescribing app, features over 140 psychiatric medications and has a dedicated Child and Adolescent section with in-depth coverage of the most commonly prescribed psychotropic drugs in pediatric patients. Continuously updated and with an interactive filter to search for medications based on key drug interactions and side effects, NEI Prescribe is your tool for point of care prescribing.
Our two annual conferences—NEI Congress in the fall and NEI Synapse in the spring—fuse learning, quality, and entertainment into an educational experience that will empower you to provide the best possible care for your patients.
We offer hundreds of online CME activities, including animations, case studies, self-assessments, and encore presentations from NEI's live events.
The Master Psychopharmacology Program is an online assessment-based certificate program designed to help clinicians develop proficiency in the practice of psychopharmacology.
Our activities can be accessed online or from the NEI Learn app—CME credits are automatically saved to your NEI transcript for a seamless CME learning experience.
Create a free NEI account at http://nei.global to take advantage of these resources. NEI Membership is required to access the full spectrum of resources, including the Master Psychopharmacology Program. Learn more at http://nei.global/mbroverview.
